Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmela Rago

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|October 29, 2021
[Which future solutions for peritoneal dialysis?]Mario Bonomini, Lorenzo Di Liberato, Carmela Rago, et al.
Toxins|March 6, 2021
A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical ExperienceCarmela Rago, Teresa Lombardi, Giorgia Di Fulvio, et al.
Clinical Rheumatology|September 16, 2017
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patientsPiero Ruscitti, Carmela Rago, Luciana Breda, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|October 29, 2021
[Which future solutions for peritoneal dialysis?]Mario Bonomini, Lorenzo Di Liberato, Carmela Rago, et al.
Toxins|March 6, 2021
A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical ExperienceCarmela Rago, Teresa Lombardi, Giorgia Di Fulvio, et al.
Clinical Rheumatology|September 16, 2017
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patientsPiero Ruscitti, Carmela Rago, Luciana Breda, et al.
Pageof 1